Complete your 2018 CMS
Quality Measures Reporting
Participate in CCACO

General Shareholder Meeting

September 15, 2012

6:30 PM - 9:30 PM

Mudan Banquet Hall
136-17 39th Avenue, 2nd floor
Flushing, NY 11354

On Saturday, September 15, 2012, CCACO held a very successful Fall Shareholder Meeting at Mudan Banquet Hall in Flushing. Thank you to everyone who attended the event. During the meeting, the CCACO Board of Directors provided an update on CCACO operations and announced that Dr. Vincent Wang was appointed as the new IT Committee Chair and President. In addition, Dr. David Zhang was appointed as a member of the Board of Directors. Congratulations to Dr. Vincent Wang and Dr. David Zhang!

Share Expansion and ACO Solution IT Platform Vote Results

During the meeting, the shareholders discussed and voted on two important issues: expanding the number of CCACO shares and selecting an ACO Solution IT platform. Dr. Garman Ho and Dr. Henry Chen presented the topic of share expansion and Dr. Vincent Wang, Chair of the IT Committee, presented the Committee's analysis of the advantages and disadvantages of several ACO solution platforms, comparison of the features and cost projections. Each member of the IT Committee fully disclosed any interest in the IT vendors considered. Both issues were discussed in an open forum that allowed shareholders to voice their opinions and raise any concerns to the CCACO leadership. After ensuring a quorum of members was reached, the CCACO general membership voted in favor of increasing the number of shares and selected MDLand as the ACO Solution IT Platform. We appreciate all of the shareholders who voiced their opinions and participated in this democratic voting process.

Final Vote Tally
Share Expansion:
*  104 Yes
41 No
ACO Solution IT Platform:
*  MDLand: 65
eClinicalWorks: 30
Cerecons: 21
Other: 8
Crimson: 0
OmniMD: 0

Investing in CCACO

In light of the approval of share expansion, CCACO members have the opportunity to increase their current CCACO shares. Each additional share may be purchased for $1,000 (i.e. $1,000 = 1 share). Founder shareholders may own no more than 24 shares. Non-founder shareholders may own no more than 20 shares. The window for purchasing additional shares will close on December 31, 2012.
PHQ-9 Depression Screening

Click here to download the PHQ-9 depression screening in English and Chinese.

Copyright 2018 CCACO Report a Compliance Issue